103 related articles for article (PubMed ID: 1786398)
21. Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture.
Yamamoto J; Nagai Y; Horie T; Awazu S
Cancer Chemother Pharmacol; 1993; 32(4):263-7. PubMed ID: 8324867
[TBL] [Abstract][Full Text] [Related]
22. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
[TBL] [Abstract][Full Text] [Related]
23. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
24. 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells.
Cory JG; Downes DL; Ng CY; Belt JA
Oncol Res; 1992; 4(4-5):175-9. PubMed ID: 1504377
[TBL] [Abstract][Full Text] [Related]
25. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T
Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686
[TBL] [Abstract][Full Text] [Related]
26. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Chinese green tea extracts on the human gastric carcinoma cell in vitro].
Yan YS
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Mar; 24(2):80-2. PubMed ID: 2364802
[TBL] [Abstract][Full Text] [Related]
28. Novel nucleoside transport inhibitors of natural origin.
Zhen YS; Su J; Xue YC; Qi CQ; Hu JL
Adv Exp Med Biol; 1994; 370():779-82. PubMed ID: 7661021
[No Abstract] [Full Text] [Related]
29. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
Potemski P; Polakowski P
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
[TBL] [Abstract][Full Text] [Related]
30. Induction of CYP1A by green tea extract in human intestinal cell lines.
Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
[TBL] [Abstract][Full Text] [Related]
31. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
32. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
33. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
Zhen YS; Taniki T; Weber G
Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
[TBL] [Abstract][Full Text] [Related]
34. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
[No Abstract] [Full Text] [Related]
35. Dioxopiperazine derivative potentiates antitumor effect of methylglyoxal bis(cyclopentylamidinohydrazone) on human and mouse leukemia cells.
Hibasami H; Tsukada T; Shirakawa S; Narita T; Inagaki M; Nakashima K
Anticancer Res; 1994; 14(2A):561-4. PubMed ID: 8017861
[TBL] [Abstract][Full Text] [Related]
36. [Studies on the bioactive constituents of Aurantii Fructus Immaturus].
Satoh Y; Tashiro S; Satoh M; Fujimoto Y; Xu JY; Ikekawa T
Yakugaku Zasshi; 1996 Mar; 116(3):244-50. PubMed ID: 8721353
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
Tsuruo T; Oh-Hara T; Sudo Y; Naito M
Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
[TBL] [Abstract][Full Text] [Related]
39. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.
Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA
J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005
[No Abstract] [Full Text] [Related]
40. Cytotoxic effects of Eleutherococcus senticosus aqueous extracts in combination with N6-(delta 2-isopentenyl)-adenosine and 1-beta-D-arabinofuranosylcytosine against L1210 leukemia cells.
Hacker B; Medon PJ
J Pharm Sci; 1984 Feb; 73(2):270-2. PubMed ID: 6707901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
